MAM
VIR icon

Meeder Asset Management’s Vir Biotechnology VIR Stock Holding History

Meeder Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,885
Closed -$137K – 610
2023
Q1 		$137K Hold
5,885
– – 0.01% 378
2022
Q4 		$149K Buy
5,885
+4,184
+246% +$103K 0.01% 442
2022
Q3 		$33K Buy
1,701
+1,607
+1,710% +$40.9K ﹤0.01% 955
2022
Q2 		$2K Buy
+94
New +$2.19K ﹤0.01% 1930
2020
Q4 		– Sell
-560
Closed -$19K – 2236
2020
Q3 		$19K Buy
560
+438
+359% +$18.9K ﹤0.01% 1190
2020
Q2 		$5K Buy
+122
New +$4.09K ﹤0.01% 1539

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return